by University of Oxford Oxford University researchers release cheap, quick COVID-19 antibody test. Credit: Shutterstock Scientists at the Oxford Parkinson’s Disease Centre (OPDC) have been able to use a highly-sensitive method called α-synuclein real-time quaking-induced conversion (αSyn-RT-QuIC) to observe the clumping of alpha-synuclein in the cerebrospinal fluid (CSF) taken from people with Parkinson’s. The findings...
Every day, millions of people take selfies with their smartphones or webcams to share online. And they almost invariably smile when they do so. “WHAT IF, WITH PEOPLE’S PERMISSION, WE COULD ANALYZE THOSE SELFIES AND GIVE THEM A REFERRAL IN CASE THEY ARE SHOWING EARLY SIGNS?” Computer vision software—based on algorithms that the researchers have...
by Denise Mann Healthday Reporter Physiotherapist David Putrino was working on a vibrating glove to help deaf people experience live music when a friend mentioned that the same technology might stop tremors in people with Parkinson’s disease. Putrino, director of rehabilitation innovation for Mount Sinai Health System in New York City, was intrigued. The friend’s...
IMAGE: UVA HEALTH NEUROSURGEON JEFF ELIAS, PHD, HAS BEEN A PIONEER IN THE DEVELOPMENT OF FOCUSED ULTRASOUND FOR THE TREATMENT OF ESSENTIAL TREMOR, A COMMON MOVEMENT DISORDER, AND PARKINSON’S DISEASE. CREDIT: UVA HEALTH The federal Food and Drug Administration has approved an incisionless form of brain surgery to treat advanced Parkinson’s disease after successful testing...
Share on Pinterest A recent study has investigated the strategies that people with Parkinson’s use to walk more easily. Solskin/Getty Images People with Parkinson’s disease who have trouble walking often invent ways to help them manage the changes to their gaits. A new study suggests that familiarity with these techniques should be more widespread. There...
Pimavanserin, a novel antipsychotic drug used to manage hallucinations and delusions in Parkinson’s disease, may lead to increased hospitalizations and deaths, according to a new study. A retrospective cohort study of elderly patients with Parkinson’s disease who were in long-term care facilities found that the use of pimavanserin (Nuplazid) was associated with an increased risk of...
by Jeff Hansen, University of Alabama at Birmingham Credit: Pixabay/CC0 Public Domain A new study, published in the journal eNeuro, suggests the answer is no. If this is borne out, that result differs from Alzheimer’s disease, where reducing endogenous tau levels in brain neurons is protective for multiple models of the disease—which further suggests that the role...
PARKINSON’S UK Wednesday 19 May 2021 – New research published today sheds important light on how the production of a key protein in the brain is controlled, which could pave the way for new treatments for a wide range of neurological conditions. In a study part-funded by Parkinson’s UK, researchers investigated a section of genetic material known...
by Mrs Amy King, University of Plymouth Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson’s disease. Credit: Wikipedia A new study has shown that anxiety amplifies the physical signs of Parkinson’s disease, according to people who experience both conditions. The study, believed to be the first to...
by Queen Mary, University of London Image of the novel capsule-based smell test. Credit: Queen Mary, University of London A new smell test developed by Queen Mary University of London researchers has been found to be easy to use in patients with Parkinson’s disease, and could also be helpful in diagnosing COVID-19 in the broader population. Smell tests...
